EVOCALCET: 43 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
43
Total FAERS Reports
6 (14.0%)
Deaths Reported
28
Hospitalizations
43
As Primary/Secondary Suspect
1
Life-Threatening
First Report: 20170720 · Latest Report: 20250317
What Are the Most Common EVOCALCET Side Effects?
#1 Most Reported
Off label use
8 reports (18.6%)
#2 Most Reported
Hospitalisation
5 reports (11.6%)
#3 Most Reported
Nausea
4 reports (9.3%)
All EVOCALCET Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 8 | 18.6% | 1 | 7 |
| Hospitalisation | 5 | 11.6% | 1 | 5 |
Who Reports EVOCALCET Side Effects? Age & Gender Data
Gender: 41.5% female, 58.5% male. Average age: 69.8 years. Most reports from: JP. View detailed demographics →
Is EVOCALCET Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2017 | 1 | 1 | 0 |
| 2018 | 7 | 1 | 4 |
| 2019 | 2 | 1 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 5 | 1 | 3 |
| 2023 | 1 | 0 | 1 |
| 2024 | 6 | 1 | 6 |
| 2025 | 2 | 0 | 2 |
What Is EVOCALCET Used For?
| Indication | Reports |
|---|---|
| Hyperparathyroidism secondary | 18 |
| Product used for unknown indication | 12 |
| Hyperparathyroidism primary | 6 |
Official FDA Label for EVOCALCET
Official prescribing information from the FDA-approved drug label.